WuXi Biologics (Cayman) Inc. Share Price OTC Markets
Equities
WXXWY
US98260N1081
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.945 USD | -6.80% | -11.69% | -60.47% |
Sales 2024 * | 18.14B 2.5B 196B | Sales 2025 * | 21.59B 2.98B 233B | Capitalization | 45.28B 6.25B 489B |
---|---|---|---|---|---|
Net income 2024 * | 3.85B 532M 41.63B | Net income 2025 * | 4.87B 672M 52.6B | EV / Sales 2024 * | 2.1 x |
Net cash position 2024 * | 7.25B 1B 78.35B | Net cash position 2025 * | 8.19B 1.13B 88.5B | EV / Sales 2025 * | 1.72 x |
P/E ratio 2024 * |
12.2
x | P/E ratio 2025 * |
9.55
x | Employees | 12,740 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.44% |
Latest transcript on WuXi Biologics (Cayman) Inc.
1 day | -6.80% | ||
1 week | -11.69% | ||
Current month | -13.38% | ||
1 month | -16.47% | ||
3 months | -35.70% | ||
6 months | -74.61% | ||
Current year | -60.47% |
Managers | Title | Age | Since |
---|---|---|---|
Zhi Sheng Chen
CEO | Chief Executive Officer | 52 | 31/05/11 |
Ming Tu
DFI | Director of Finance/CFO | 54 | 22/08/21 |
Gu Jijie
CTO | Chief Tech/Sci/R&D Officer | 57 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Jackson Tai
BRD | Director/Board Member | 73 | 05/05/23 |
William Keller
BRD | Director/Board Member | 75 | 16/05/17 |
Ge Li
CHM | Chairman | 56 | 30/04/10 |
Date | Price | Change | Volume |
---|---|---|---|
28/05/24 | 2.945 | -6.80% | 245 953 |
24/05/24 | 3.16 | -0.88% | 42,127 |
23/05/24 | 3.188 | -3.74% | 110,185 |
22/05/24 | 3.312 | -0.69% | 90,424 |
21/05/24 | 3.335 | -4.71% | 79,173 |
Delayed Quote OTC Markets, May 28, 2024 at 07:38 pm
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.82% | 118B | |
+9.99% | 106B | |
-11.41% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.46% | 15.97B | |
+6.66% | 14.03B | |
+16.59% | 11.67B |
- Stock Market
- Equities
- 2269 Stock
- WXXWY Stock